AMGEN REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Amgen (AMGN) Tops Q2 EPS by 26c, Offers Guidance
August 4, 2022 4:03 PM EDTAmgen (NASDAQ: AMGN) reported Q2 EPS of $4.65, $0.26 better than the analyst estimate of $4.39. Revenue for the quarter came in at $6.59 billion versus the consensus estimate of $6.53 billion.
GUIDANCE:
Amgen sees FY2022 EPS of $17.00-$18.00, versus the consensus of $17.40. Amgen sees... More
